Data submitted to the UK drugs regulator show a total of 82 deaths related to glucagon-like peptide-1 receptor agonists, the class of drugs used for weight loss and type 2 diabetes. https://www.bmj.com/content/388/bmj.r390

This is frightening as huge quantities of people are taking them. A staggering 12% of the UK has taken a GLP-1 Agonist. 

Is this something we should be worried about?

Is Ozempic and other GLP-1 Agonists dangerous?

523,000 people have taken them in total, so the estimated mortality rate is only 0.016%. 

What should we take from this data?

Type 2 diabetes and obesity causes 2.3 million deaths per year worldwide and obesity kills 2.8 million people per year. 

That’s a lot of people. 

GLP-1 Agonists drastically reduce rates of obesity and Type 2 diabetes by reducing people’s appetite and therefore reducing their weight and blood sugar. 

GLP-1 Agonists will therefore have a drastic effect on the number of people dying worldwide from Obesity and Type 2 diabetes. 

You’re now shouting but James it’s so expensive only rich people can afford it. 

Here’s the thing the more people that use it the cheaper it will become. 

I can tell you one thing being obese will a 100 percent do more harm to your health than taking Ozempic. 

Just be aware it’s not side effect free!